LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B

A. Aabas; M. Berzioli; P. Brisotto; P. Caliandro; G. Chirico; F. Colonna; V. Curro; B. De Mitri; U. De Vonderweid; A. Del Prete; R. Giorgi; G. Latini; F. Morandi; C. Passerini; L. Quartulli; E. Rosati; A. Taborelli; E. Visona; R. Zanini

LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B

Translated title of the contribution: Treatment of group B streptococcus neonatal septicemia

A. Aabas, M. Berzioli, P. Brisotto, P. Caliandro, G. Chirico, F. Colonna, V. Curro, B. De Mitri, U. De Vonderweid, A. Del Prete, R. Giorgi, G. Latini, F. Morandi, C. Passerini, L. Quartulli, E. Rosati, A. Taborelli, E. Visona, R. Zanini

IRCCS pediatrico Burlo Garofolo

Research output: Contribution to journal › Article › peer-review

Abstract

Expectant therapy for early Group B Streptococcus onset septicemia must provide coverage against other microrganisms, such as L. Monocytogenes, H. Influenzae and S. Pneumoniae. It is possible to administer a combination of antimicrobial agents with activity against all or the most likely pathogens. Thus initial expectant therapy includes a broad spectrum semisynthetic penicillin (e.g. ampicillin) and an aminoglycoside (e.g. netilmicin). Vancomycin, teicoplanin and cefotaxime may also be used. Supportive therapy consists of temperature control, i.v. administration of fluids, acid-base balance and electrolytes monitoring, seizures control and ventilation. I.V. immunoglobulins, granulocyte and serum transfusion are also used. The G-Golony Stimulating Factor (G-CSF, filgastrim) usage is also reported.

Translated title of the contribution	Treatment of group B streptococcus neonatal septicemia
Original language	Italian
Pages (from-to)	305-306
Number of pages	2
Journal	Pediatria Medica e Chirurgica
Volume	17
Issue number	4
Publication status	Published - 1995

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Treatment of group B streptococcus neonatal septicemia'. Together they form a unique fingerprint.

Cite this

Aabas, A., Berzioli, M., Brisotto, P., Caliandro, P., Chirico, G., Colonna, F., Curro, V., De Mitri, B., De Vonderweid, U., Del Prete, A., Giorgi, R., Latini, G., Morandi, F., Passerini, C., Quartulli, L., Rosati, E., Taborelli, A., Visona, E., & Zanini, R. (1995). LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B. Pediatria Medica e Chirurgica, 17(4), 305-306.

LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B. / Aabas, A.; Berzioli, M.; Brisotto, P.; Caliandro, P.; Chirico, G.; Colonna, F.; Curro, V.; De Mitri, B.; De Vonderweid, U.; Del Prete, A.; Giorgi, R.; Latini, G.; Morandi, F.; Passerini, C.; Quartulli, L.; Rosati, E.; Taborelli, A.; Visona, E.; Zanini, R.

In: Pediatria Medica e Chirurgica, Vol. 17, No. 4, 1995, p. 305-306.

Research output: Contribution to journal › Article › peer-review

Aabas, A, Berzioli, M, Brisotto, P, Caliandro, P, Chirico, G, Colonna, F, Curro, V, De Mitri, B, De Vonderweid, U, Del Prete, A, Giorgi, R, Latini, G, Morandi, F, Passerini, C, Quartulli, L, Rosati, E, Taborelli, A, Visona, E & Zanini, R 1995, 'LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B', Pediatria Medica e Chirurgica, vol. 17, no. 4, pp. 305-306.

Aabas, A. ; Berzioli, M. ; Brisotto, P. ; Caliandro, P. ; Chirico, G. ; Colonna, F. ; Curro, V. ; De Mitri, B. ; De Vonderweid, U. ; Del Prete, A. ; Giorgi, R. ; Latini, G. ; Morandi, F. ; Passerini, C. ; Quartulli, L. ; Rosati, E. ; Taborelli, A. ; Visona, E. ; Zanini, R. / LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B. In: Pediatria Medica e Chirurgica. 1995 ; Vol. 17, No. 4. pp. 305-306.

@article{8d075e4d8f24458197aa62177e63a766,

title = "LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B",

abstract = "Expectant therapy for early Group B Streptococcus onset septicemia must provide coverage against other microrganisms, such as L. Monocytogenes, H. Influenzae and S. Pneumoniae. It is possible to administer a combination of antimicrobial agents with activity against all or the most likely pathogens. Thus initial expectant therapy includes a broad spectrum semisynthetic penicillin (e.g. ampicillin) and an aminoglycoside (e.g. netilmicin). Vancomycin, teicoplanin and cefotaxime may also be used. Supportive therapy consists of temperature control, i.v. administration of fluids, acid-base balance and electrolytes monitoring, seizures control and ventilation. I.V. immunoglobulins, granulocyte and serum transfusion are also used. The G-Golony Stimulating Factor (G-CSF, filgastrim) usage is also reported.",

author = "A. Aabas and M. Berzioli and P. Brisotto and P. Caliandro and G. Chirico and F. Colonna and V. Curro and {De Mitri}, B. and {De Vonderweid}, U. and {Del Prete}, A. and R. Giorgi and G. Latini and F. Morandi and C. Passerini and L. Quartulli and E. Rosati and A. Taborelli and E. Visona and R. Zanini",

year = "1995",

language = "Italian",

volume = "17",

pages = "305--306",

journal = "Pediatria Medica e Chirurgica",

issn = "0391-5387",

publisher = "Vicenza Pediatria Medica E Chirurgica",

number = "4",

}

TY - JOUR

T1 - LA TERAPIA DELL'INFEZIONE NEONATALE DA STREPTOCOCCO BETA-EMOLITICO DI GRUPPO B

AU - Aabas, A.

AU - Berzioli, M.

AU - Brisotto, P.

AU - Caliandro, P.

AU - Chirico, G.

AU - Colonna, F.

AU - Curro, V.

AU - De Mitri, B.

AU - De Vonderweid, U.

AU - Del Prete, A.

AU - Giorgi, R.

AU - Latini, G.

AU - Morandi, F.

AU - Passerini, C.

AU - Quartulli, L.

AU - Rosati, E.

AU - Taborelli, A.

AU - Visona, E.

AU - Zanini, R.

PY - 1995

Y1 - 1995

N2 - Expectant therapy for early Group B Streptococcus onset septicemia must provide coverage against other microrganisms, such as L. Monocytogenes, H. Influenzae and S. Pneumoniae. It is possible to administer a combination of antimicrobial agents with activity against all or the most likely pathogens. Thus initial expectant therapy includes a broad spectrum semisynthetic penicillin (e.g. ampicillin) and an aminoglycoside (e.g. netilmicin). Vancomycin, teicoplanin and cefotaxime may also be used. Supportive therapy consists of temperature control, i.v. administration of fluids, acid-base balance and electrolytes monitoring, seizures control and ventilation. I.V. immunoglobulins, granulocyte and serum transfusion are also used. The G-Golony Stimulating Factor (G-CSF, filgastrim) usage is also reported.

AB - Expectant therapy for early Group B Streptococcus onset septicemia must provide coverage against other microrganisms, such as L. Monocytogenes, H. Influenzae and S. Pneumoniae. It is possible to administer a combination of antimicrobial agents with activity against all or the most likely pathogens. Thus initial expectant therapy includes a broad spectrum semisynthetic penicillin (e.g. ampicillin) and an aminoglycoside (e.g. netilmicin). Vancomycin, teicoplanin and cefotaxime may also be used. Supportive therapy consists of temperature control, i.v. administration of fluids, acid-base balance and electrolytes monitoring, seizures control and ventilation. I.V. immunoglobulins, granulocyte and serum transfusion are also used. The G-Golony Stimulating Factor (G-CSF, filgastrim) usage is also reported.

UR - http://www.scopus.com/inward/record.url?scp=0028818764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028818764&partnerID=8YFLogxK

M3 - Articolo

C2 - 7491323

AN - SCOPUS:0028818764

VL - 17

SP - 305

EP - 306

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 4

ER -